/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments

immunotherapy

Tag

Latest Stories

Eat It Up
9.16.22, 11:51 AM EDT on neoscope
New Treatment Turns Cancer Genes Into "Eat Me" Signs For Immune System
Cancer Culture
6.6.22, 12:25 PM EDT on neoscope
Scientists Intrigued by Treatment That Put Every Single Patient's Cancer Into Remission
Cancer Vaccines H...
3.26.21, 3:50 PM EDT on neoscope
Scientists Complete First Human Test of Vaccine Against Brain Cancer
Seek and Destroy
Updated 4.5.19, 12:01 PM EDT on neoscope
First-of-Its-Kind HIV Therapy Draws out the Virus, Then Kills It
Futurism
2.2.18, 10:09 AM EST on neoscope
Cancer "Vaccine" That Wipes out Tumors Ready for Human Trial
Futurism
12.11.17, 3:15 PM EST on neoscope
Immunotherapy Drug Proven Remarkably Successful Against Serious Stem Cell Transplant Complication
Futurism
Updated 11.29.17, 9:55 PM EST on neoscope
New Study Finds Parkinson's is Partly an Autoimmune Disease
Futurism
Updated 11.20.17, 11:48 AM EST on neoscope
Scientists Engineer Nonimmune Cells That Kill Cancer Upon Contact
Futurism
Updated 10.19.17, 9:49 AM EDT on neoscope
FDA Approves Radical New Gene-Altering Cancer Treatment
Futurism
10.17.17, 7:48 PM EDT on futurism
Scientists Just Unlocked the Catalyst for Cancerous Relapse
Futurism
6.6.17, 12:01 PM EDT on neoscope
A New Gene Therapy Could Hold the Key to Curing Allergies and Asthma
Futurism
5.25.17, 12:02 PM EDT on neoscope
The FDA Just Approved a First-Of-Its-Kind Drug That Targets Cancer's Genes
  • Previous
  • 1
  • 2
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.